Certain injectable formulations discussed on this page are FDA-approved for specific indications (e.g., cyanocobalamin for vitamin B12 deficiency)
This pattern is consistent across nutrient-based interventions: the magnitude of benefit often correlates with the degree of pre-existing insufficiency
One clinical trial of pregnant and lactating mothers found that mothers needed to consume 3 times the recommended amounts of vitamin B12 to maintain adequate vitamin B12 status throughout pregnancy and lactation
most of the B 12 secreted in the bile is recycled via enterohepatic circulation
Evidence base: Preclinical murine studies (intraperitoneal route only) Form covered on this page: 250 mcg oral capsule, 100 capsules per bottle Reference murine dose: ~12502500 mcg/day, split into two doses (IP route) Educational oral framework: 2501000 mcg/day, split across the day Storage: Sealed bottle at room temperature, away from light and moisture Status: For research use only
Animal toxicology signals Two animal findings reviewed by FDA are worth tracking even if they did not surface clinically